Cargando…
Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
Cyclooxygenase-2 (COX-2) is reported to be activated during the course of amyotrophic lateral sclerosis (ALS) development and progression. However, the roles of COX-2 in aggravating ALS and the underlying mechanism have been largely overlooked. To reveal the mechanisms, the canonical SOD1(G93A) mous...
Autores principales: | Zou, Yan-Hui, Guan, Pei-Pei, Zhang, Shen-Qing, Guo, Yan-Su, Wang, Pu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438558/ https://www.ncbi.nlm.nih.gov/pubmed/32903591 http://dx.doi.org/10.3389/fnins.2020.00817 |
Ejemplares similares
-
Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015) -
Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis
por: Zhou, Wan, et al.
Publicado: (2023) -
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
por: Tafuri, Francesco, et al.
Publicado: (2015) -
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
por: Tefera, Tesfaye W., et al.
Publicado: (2017) -
Editorial: New Insights Into the Molecular Mechanism of Amyotrophic Lateral Sclerosis Pathogenesis
por: Li, Cheng, et al.
Publicado: (2022)